Botanical species · safety record

Arundo donax

The EFSA Compendium of Botanicals holds 16 constituent measurements for Arundo donax. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Arundo donax L.

16Constituent measurements
0Safety records
10Cited sources
3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Arundo donax as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Fresh underground part(s)

What the records describe

Constituents measured

  • Indole alkaloids5
  • Gramine2
  • 3-methylindole1
  • Alkaloids1
  • Asarone1
  • Benzaldehyde1
  • Bufotenine1
  • Carboline alkaloids1
  • Donasine1
  • Indole1

Plant parts

  • Roots and other underground parts7
  • Aerial part of plants6
  • Leaves2
  • Shoot1

Preparations

  • Solvent extraction16

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AsaroneRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
BenzaldehydeRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
BufotenineAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Carboline alkaloidsRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
DonasineRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
GramineShootSolvent extraction0.0173 Millimole/kilogramLC-MS/MSResolve DOI
Indole alkaloidsRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Indole alkaloidsAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Indole alkaloidsRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Indole alkaloidsAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
SyringaresinolRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
3-methylindoleAerial part of plantsSolvent extractionGC-MSNo resolvable identifier
AlkaloidsLeavesSolvent extractionTraditional analytical techniques (wet chemical tests)No resolvable identifier
GramineAerial part of plantsSolvent extractionGC-MSNo resolvable identifier
IndoleAerial part of plantsSolvent extractionGC-MSNo resolvable identifier
Indole alkaloidsLeavesSolvent extractionTraditional analytical techniques (wet chemical tests)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Zhalolov, IZ., Khuzhaev, VU., Turgunov, KK., Tashkhodzhaev, B., Aripova, SF. Alkaloids of Arundo donax. XIV. Crystal and molecular structure of N-methyl-tetrahydro-beta-carboline . Chemistry of natural compounds, 2003, vol. 39, no. 3, p. 289-291. DOI
  2. Jia, A. -L., Ding, X. -Q., Chen, D. -L., Chao, Z. -Z., Liu, Z. -Y., Chao, R. -B. A new indole alkaloid from Arundo donax L.. Journal of asian natural products research, 2008, vol. 10, no. 2, p. 105-109. DOI
  3. Zhalolov, I., Khuzhaev, VU., Levkovich, MG., Aripova, SF. Alkaloids of Arundo donax. VIII. 3-alkylindole derivatives in A-donax. Chemistry of natural compounds, 2000, vol. 36, no. 5, p. 528-530. DOI
  4. Madinaveitia, J. The alkaloids of Arundo donax L.. Journal of the chemical society (resumed), 1937, p. 1927-1929.
  5. Hong, Y., Hu, H. Y., Sakoda, A., Sagehashi, M. Isolation and characterization of antialgal allelochemicals from Arundo donax L. . Allelopathy journal, 2010, vol. 25, no. 2, p. 357-367.
  6. Liu, Q.-R., Li, J., Zhao, X.-F., Xu, B., Peng, W.-D., Li, S.-X. Studies on constituents from rhizome of Arundo donax. Chinese traditional and herbal drugs, 2016, vol. 47, no. 7, p. 1084-1089. DOI
  7. Kokubo, Yu., Nishizaka, Miho., Ube, Naoki., Yabuta, Yukinori., Tebayashi, Shin-ichi., Ueno, Kotomi., Taketa, Shin., Ishihara, Atsushi. Distribution of the tryptophan pathway-derived defensive secondary metabolites gramine and benzoxazinones in Poaceae . Bioscience biotechnology and biochemistry, 2017, vol. 81, no. 3, p. 431-440. DOI
  8. Khuzhaev, VU., Zhalolov, I., Turgunov, KK., Tashkhodzhaev, B., Levkovich, MG., Aripova, SF., Shashkov, AS. Alkaloids from Arundo donax. XVI. Structure of the new dimeric indole alkaloid arundavine . Chemistry of natural compounds, 2004, vol. 40, no. 3, p. 261-265. DOI
  9. Khuzhaev, VU., Zhalolov, IZ., Levkovich, MG., Aripova, SF., Shashkov, AS. Alkaloids of Arundo donax L. 15. A new dimeric indole alkaloid arundarine from the roots of Arundo donax L. . Russian chemical bulletin, 2004, vol. 53, no. 8, p. 1765-1767. DOI
  10. Rhuzhaev, V.U., Tashkhodzhaev, B., Aripova, S.F. Alkaloids of Arundo donax. III. Reconsideration of the structures of donaxarine and donaxaridine. Chemistry of natural compounds, 1995, vol. 31, no. 5, p. 604-609. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue